Pharmacovigilance Market Growth Trends: Moderate Expansion with 12.6% CAGR Until 2029

 Get 20% Off All Market Studies With Code ONLINE20 — Anticipate Tariff Impacts, Market Disruptors, and Long-Term Growth Trends

 

 What Is the Estimated Market Growth Potential of the Pharmacovigilance Market by 2029?
 The pharmacovigilance market size has grown rapidly in recent years. It will grow from $8.58 billion in 2024 to $9.64 billion in 2025 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to the increasing incidence of adverse drug reactions (ADRs), the increasing research and development (R&D) activities, the growing drug development rates, the increasing focus on personalized medicine, and the rising prevalence of chronic diseases.
 
 The pharmacovigilance market size is expected to see rapid growth in the next few years. It will grow to $15.5 billion in 2029 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to the rising healthcare expenditure, the increasing government support and the aging population. Major trends in the forecast period include increasing investments, use of artificial intelligence, use of innovative platforms, use of innovative cloud-based systems, and strategic mergers and acquisitions.
 
 Claim your free report sample now:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=5928&type=smp
 
 Which Key Growth Contributors Will Drive the Pharmacovigilance Market in the Next Decade?
 The increasing research and development activities will drive the pharmacovigilance market. By investing in R&D, pharmaceutical companies can develop new and innovative drugs with improved safety profiles. Rigorous preclinical and clinical testing during the drug development process enables early identification of potential safety concerns, allowing for appropriate risk mitigation strategies to be implemented. Additionally, R&D efforts contribute to the advancement of technologies for adverse event monitoring, data analysis, and signal detection, facilitating the early detection of adverse drug reactions in the post-marketing phase. For instance, in February 2024, according to Llywodraeth Cymru Welsh Government, a UK-based government agency, in 2022 Wales invested £1.0 billion ($1.25 billion) in Business Expenditure on Research and Development (BERD), accounting for 1.9% of the total UK expenditure in this area. Therefore, the increasing research and development activities supported the growth of the pharmacovigilance market. 
 
 What Segments Are Covered in the Pharmacovigilance Market Report?
 The pharmacovigilance market covered in this report is segmented — 
 
 1) By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining
 2) By Service Provider: In-House, Contract Outsourcing
 3) By Process Flow: Case Data Management, Signal Detection, Risk Management System
 4) By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, Phase IV
 5) By End User: Hospitals, Pharmaceutical Companies, Other End Users
 
 Subsegments:
 1) By Spontaneous Reporting: Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, Case Reports From Healthcare Professionals 
 2) By Intensified ADR Reporting: Active Surveillance Programs, Enhanced Monitoring In Clinical Trials, Risk Minimization Strategies 
 3) By Targeted Spontaneous Reporting: Reporting For Specific Drug Classes, Condition-Specific Reporting, Focused Surveillance Programs 
 4) By Cohort Event Monitoring: Prospective Cohort Studies, Retrospective Cohort Studies, Longitudinal Studies 
 5) By EHR Mining: Data Extraction From Electronic Health Records, Signal Detection Through EHR Analysis, Integration Of EHR Data With Pharmacovigilance Systems 
 
 What Are the Key Trends Shaping the Pharmacovigilance Market?
 Companies in the pharmacovigilance market are focusing on artificial intelligence (AI) to improve efficiency. AI can help improve the efficiency and accuracy of pharmacovigilance activities, ultimately leading to better patient outcomes. By utilizing AI, pharma companies can streamline their processes, improve data management, and accelerate drug discovery, while simultaneously reducing costs and improving safety. For instance, in August 2024, the Government of India launched the Adverse Drug Reaction Monitoring System (ADRMS) software, introduced by the Minister of Health & Family Welfare and Minister of Chemicals and Fertilizers. This pharmacovigilance software facilitates the collection and analysis of adverse events related to medicines and medical devices, making the reporting process easier for both consumers and healthcare professionals. This initiative significantly strengthens India’s pharmacovigilance infrastructure by ensuring a more comprehensive capture of safety data and enhancing drug safety monitoring. The ADRMS aims to improve the efficiency of drug safety oversight and compliance with standards, helping position India as a leader in the global pharmaceutical industry. 
 
 Who Are the Most Influential Players in the Pharmacovigilance Market?
 Major companies operating in the pharmacovigilance market include IQVIA, Cognizant, ICON Plc, Accenture plc, PAREXEL International Corporation., United BioSource LLC, ArisGlobal, Quanticate, Wipro Limited, Linical Americas, Novotech CRO, Wuxi Apptec, Simcere Pharmaceutical Group, Lee’s Pharmaceutical Holdings, Luye Pharma Group, EXTEDO, Arriello, PrimeVigilance, Axios International, C3i Solutions, Alcon, Secure AI Labs, OmniSol dot Tech, Canna Call Company, Veripad, Prevnos Inc., Lifescient, Inc, BeiGene, QuintilesIMS, Labcorp Drug Development, Pharmaceutical Product Development Inc., PRA Health Sciences, Synowledge LLC, RAPAhub, illuminate health, Invenio Medical, ClinChoice Inc., MSD, Novasyte, Fortrea Holdings Inc, Syneos Health Clinical, Zoetis Inc., Telerx Marketing Inc., Gilead Sciences, Inc., Elanco, Abbott Laboratories, Spimaco, Teva Pharmaceutical Industries Ltd. 
 
 Get the full pharmacovigilance market report here:
 https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report
 
 Which Region Is Projected to Account for the Largest Share of the Pharmacovigilance Market?
 North America was the largest region in the pharmacovigilance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast region. The regions covered in the pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company